S. Huck et al., Abnormal DNA methylation and deoxycytosine-deoxyguanine content in nucleosomes from lymphocytes undergoing apoptosis, FASEB J, 13(11), 1999, pp. 1415-1422
Systemic lupus erythematosus (SLE) is characterized by an accelerated apopt
osis of peripheral lymphocytes and an impairment of the clearance of apopto
tic cells, Since changes in DNA methylation and in deoxycytosine and deoxyg
uanine (GC) content have been shown to enhance the potential of DNA to acti
vate murine and human B lymphocytes, we tested the capacity of lymphocytes
undergoing apoptosis (under conditions that mimic the deletion of self-reac
tive cells after antigen receptor engagement) to generate nucleosomes with
a particular base composition. Using two cell culture systems and four apop
tosis triggers, we found an increase of deoxymethylcytosine in fragmented c
hromosomal DNA of apoptotic B and T lymphocytes. However, this increase was
not associated with modulation of DNA (cytosine-5) methyltransferase, the
enzyme that methylates eukaryotic DNA, which suggests that the changes in D
NA methylation patterns are not linked to the process of de novo DNA methyl
ation during cell death. In addition, we could not detect a unique methylat
ion pattern in highly repetitive Alu sequences present in the human genome
of SLE subjects, as compared with controls, However, the abnormal DNA methy
lation of apoptotic nucleosomes was associated with an unusual pattern of n
uclease-resistant, GC-rich regions in these DNA fragments. We propose that
the combination of an accelerated apoptosis with a defect in the clearance
of apoptotic cells results in release of increased amounts of nucleosomes w
ith abnormally methylated, GC-rich DNA and provides an autologous stimulati
on that could bypass tolerance to self in systemic autoimmune diseases. The
se findings support the concept that the structure and dynamics of nucleoso
mes are critical in determining their immunogenicity in SLE.